Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVRP.L Share News (VRP)

  • There is currently no data for VRP

VRP.L News

Advanced Oncotherapy CEO makes triple purchase
26 Apr 2013

Advanced Oncotherapy CEO makes triple purchase

The Chief Executive of Advanced Oncotherapy, a provider of new technology for innovative and patient-focused cancer treatments, has this week purchase...

AZ Electronic Materials directors try to minimize damage
10 Apr 2013

AZ Electronic Materials directors try to minimize damage

John Whybrow, the Chairman of AZ Electronic Materials, which on Tuesday tanked after it issued a warning on full year revenue, has shown his faith in ...

Small caps round-up: Verona, Image Scan, Avia
4 Sep 2012

Small caps round-up: Verona, Image Scan, Avia

Respiratory diseases specialist Verona Pharma has hailed a positive outcome of a clinical trial of its lead drug candidate, the snappily-named RPL554....

Small caps round-up: Transense Tech, Hightex, Verona Pharma
28 Aug 2012

Small caps round-up: Transense Tech, Hightex, Verona Pharma

Transense Technologies, which provides sensor systems for the transportation and industrial markets, has reported that its trading division, Translogi...

Small caps round-up: Lighthouse, Verona Pharma, Manroy...
9 Jul 2012

Small caps round-up: Lighthouse, Verona Pharma, Manroy...

Shares in Lighthouse Group, the financial advice and wealth management group, plunged on Monday after the company proposed to cancel its listing on AI...

Small caps round-up: Verona Pharma, PHSC, Sterling Green
26 Nov 2010

Small caps round-up: Verona Pharma, PHSC, Sterling Green

Verona Pharma, respiratory diseases treatment developer, is initiating a new higher dose trial of its lead drug, RPL554, in patients with asthma, afte...

Verona Pharma In Talks With Licensees For RPL554 Cough Project
28 Jun 2010

Verona Pharma In Talks With Licensees For RPL554 Cough Project

LONDON (Dow Jones)--Verona Pharma PLC (VRP.LN), an AIM quoted drug discovery company, said Monday licensing discussions continue to advance with poten...